At the news
? NEUTRALIMPACT 3/10 COURT-RULING filed May 17, 2026 at 20:00 ET
The Illinois Appellate Court affirmed summary judgment for AbbVie in a product liability case over its XEN gel stent. The plaintiff failed to provide expert testimony that a manufacturing defect caused his injuries, ending the litigation in AbbVie's favor.
- Appellate court affirmed summary judgment for AbbVie in strict product liability action.
- Plaintiff alleged XEN gel stent had chemical residue causing eye injuries but lacked expert causation evidence.
- Non-precedential order under Illinois Supreme Court Rule 23(e)(1).
- No damages awarded, no injunction, no class action.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access